📰 Binish Chudgar News
Page 2 - Binish Chudgar News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Binish Chudgar. Real-time updates on events, politics, business and more.
June 29, 2022
/PRNewswire/ -- EVERSANA, the pioneer of next-generation commercial services to the global life sciences industry, and Accord BioPharma, the U.S. specialty...
May 10, 2022
Myovant Sciences and Accord Healthcare enter into exclusive license agreement to commercialize ORGOVYX
May 9, 2022
Myovant Sciences and Accord Healthcare, Ltd. Enter into Exclusive License Agreement to Commercialize ORGOVYX® for Advanced Hormone-Sensitive Prostate Cancer in Europe - read this article along with other careers information, tips and advice on BioSpace
April 19, 2022
Comera will develop a differentiated formulation of an Intas product using Comera's innovative proprietary SQore formulation platform
April 4, 2022
/PRNewswire/ -- Accord BioPharma, the U.S. specialty division of Intas Pharmaceuticals, Ltd. focused on development of oncology, immunology, and critical care...
January 8, 2021
Intas Pharma inks licensing agreement with Korean firm to develop new products Intas Pharma inks licensing agreement with Korean firm to develop new products 08 January 2021 | News Alteogen will receive an initial payment of $6 million and is also eligible to receive additional milestones upon Intas’ achievement of specified development, regulatory and sales milestones, totalling up to $109 million Source credit: Shutterstock South Korean firm Alteogen Inc has announced that it has e...